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Abstract
Background: Elderly patients undergoing open pancreatoduodenectomy (OPD) are at increased risk
for surgical morbidity and mortality. Whether totally laparoscopic pancreatoduodenectomy (TLPD) miti-
gates these risks has not been evaluated.
Methods: A retrospective review of outcomes in patients submitted to pancreatoduodenectomy
during 2007–2014 was conducted (n = 860). Outcomes in elderly patients (aged ≥70 years) were
compared with those in non-elderly patients with respect to risk-adjusted postoperative morbidity and
mortality. Differences in outcomes between patients submitted to OPD and TLPD, respectively, were
evaluated in the elderly subgroup.
Results: In elderly patients, the incidences of cardiac events (odds ratio [OR] 3.21, P < 0.001), respi-
ratory events (OR 1.68, P = 0.04), delayed gastric emptying (DGE) (OR 1.73, P = 0.003), increased
length of stay (LoS, 1 additional day) (P < 0.001), discharge disposition other than home (OR 8.14,
P < 0.001) and blood transfusion (OR 1.48, P = 0.05) were greater than in non-elderly patients. Morbidity
and mortality did not differ between the OPD and TLPD subgroups of elderly patients. In elderly
patients, OPD was associated with increased DGE (OR 1.80, P = 0.03), LoS (1 additional day;
P < 0.001) and blood transfusion (OR 2.89, P < 0.001) compared with TLPD.
Conclusions: Elderly patients undergoing TLPD experience rates of mortality, morbidity and
cardiorespiratory events similar to those in patients submitted to OPD. In elderly patients, TLPD offers
benefits by decreasing DGE, LoS and blood transfusion requirements.
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Introduction
Pancreatoduodenectomy (PD) has been performed for almost
a century and minimally invasive approaches to this procedure
have been introduced since the mid-1990s.1–4 Although
improvements in overall morbidity and mortality have been
observed over time, elderly patients represent one patient
group that remains vulnerable to the risks associated with this
procedure.5,6 A prior review at the present authors’ institution
suggested PD could be safely performed in well-selected
patients of >70 years of age with acceptable perioperative out-
comes.7 Subsequent studies have demonstrated increased post-
operative mortality, intensive care unit (ICU) admission and
cardiorespiratory morbidity in elderly compared with non-
elderly patients.8,9 Despite these findings, PD may be safely
performed in octogenarians with malignant diagnoses and
offers a survival benefit to these patients.10
Studies evaluating strategies to improve perioperative out-
comes in elderly patients undergoing PD are lacking. Mini-
mally invasive approaches to pancreatectomy have
demonstrated decreases in postoperative pain, hospital length
of stay (LoS) and surgical morbidity.11,12 Totally laparoscopic
PD (TLPD) has been shown to be safe and effective in several
studies13–15 and is associated with decreases in hospital LoS
and operative blood loss compared with open PD (OPD).13
This study was presented as a long oral presentation at the Annual
Meeting of the AHPBA, 11–15 March 2015, Miami, Florida.
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Major venous resection during TLPD has also been reported to
have short-term outcomes comparable with those of OPD.16
Importantly, retrospective comparative studies now demon-
strate that oncologic outcomes of TLPD are comparable with
those of OPD.13,17
Robotic PD has demonstrated perioperative outcomes in
elderly patients of >70 years of age equivalent to those in the
non-elderly population.18 However, the effects of TLPD on
perioperative morbidity and mortality, specifically in elderly
patients, in comparison with OPD have not been evaluated.
Thus, the objectives of the present study were: (i) to compare
postoperative outcomes in elderly (≥70 years) and non-elderly
patients undergoing PD, and (ii) to determine if TLPD will
mitigate increased postoperative morbidity in elderly patients
compared with OPD. The study hypothesis assumed that
TLPD might mitigate risks associated with OPD in elderly
patients.
Materials and methods
Data sources
A single-institution, retrospective review of a prospectively
maintained pancreatic surgery database was conducted. Details
regarding patient demographics, comorbidities, clinical presen-
tation, operative details, pathology reports, biochemical data,
postoperative outcomes and surgical follow-up were extracted
by chart review of medical records. The study protocol was
approved by the Institutional Review Board of the Mayo Clinic
(Rochester, MN, USA).
Study subjects
Consecutive patients submitted to PD between June 2007
(when TLPD was introduced at this institution) and June 2014
were evaluated. The study institution states a preference for
pylorus preservation, two-layer duct-to-mucosa pancreaticoje-
junostomy, single-layer end-to-side hepaticojejunostomy, and
double-layer duodenojejunostomy in both TLPD and OPD.
The techniques of TLPD with and without vein resection have
been previously described.14,19 Decisions on the placement of
operative drains and feeding jejunostomy tubes are made at
the time of operation and are based on the surgeon’s judge-
ment and preferences. The study protocol permitted the inclu-
sion of patients undergoing elective PD for any indication with
or without concomitant procedures such as diagnostic laparo-
scopy, biopsy, lysis of adhesions, resection of an adjacent organ
and/or resection of other intra-abdominal organ(s). Exclusion
criteria denied the inclusion of patients in whom PD was per-
formed emergently and patients without explicit institutional
research authorization. Elderly patients were defined as patients
aged ≥70 years. This age cut-off was consistent with a prior
review of outcomes conducted at the study institution7 and
other comparative studies evaluating outcomes in elderly
patients undergoing minimally invasive PD,18 and provided a
distribution of patients that allowed for meaningful statistical
analyses. In the first analysis, the entire cohort was evaluated
and perioperative outcomes were compared among elderly and
non-elderly patients. In the second analysis, outcomes of OPD
were compared with those of TLPD in the elderly patient sub-
group. Evaluation was based on the two study objectives.
Outcomes
Outcomes of interest were postoperative mortality, postoperative
morbidity and hospital resource utilization. Mortality was
defined as any in-hospital death or death within 30 days of the
time of surgery. Surgical morbidity was captured for 30 days
from the date of operation based upon in-hospital occurrences,
readmissions and routine follow-up information. Cardiac events
were captured and defined as any myocardial infarction, cardiac
arrest, unstable arrhythmias requiring intervention and transfer
to a monitored unit, or congestive heart failure. Respiratory
events were defined as any respiratory failure, prolonged ventila-
tor support for >48 h or pneumonia. Surgical site infections
were defined as any superficial, deep or organ space infection
with or without associated wound and/or fascial dehiscence.
Complications were graded on severity according to the
Clavien–Dindo classification. Major morbidity was defined as a
complication of Clavien–Dindo Grade IIIb or higher.20
Pancreas-specific outcomes such as postoperative pancreatic fis-
tula (POPF), post-pancreatectomy haemorrhage (PPH) and
delayed gastric emptying (DGE) were classified based on Inter-
national Study Group of Pancreatic Surgery definitions.21–23
Outcomes related to hospital resource utilization were
defined by admission to ICUs, reoperations, readmissions, hos-
pital LoS, receipt of blood transfusion(s), and discharge dispo-
sition other than home, such as another hospital, rehabilitation
centre or skilled nursing facility. Reoperations and readmis-
sions were captured for up to 30 days. Reoperations and read-
missions outside the study institution were confirmed through
outside institutional charts that were also reviewed to capture
additional morbidity related to these occurrences. Any
unplanned admissions to the ICU on either the index hospital
admission or readmission were also captured. Postoperative
blood transfusion was defined as any receipt of packed red
blood cells (PRBC) during the course of hospitalization.
Length of stay was the duration of hospitalization from the
date of surgery until the time of index discharge.
Statistical analysis
Univariate tests of association were conducted to identify
statistically significant differences between elderly and non-
elderly patients in the cohort analysis, as well as between
patients undergoing OPD and TLPD, respectively, in the
elderly patient subgroup. Data were analysed using t-tests for
continuous variables and chi-squared or Fisher’s exact tests for
categorical variables. Statistical significance was defined at the
0.05 level. Intention-to-treat and as-treated analyses for uni-
variate outcomes were conducted for the subgroup analysis
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Table 1 Baseline characteristics in the entire patient cohort
Variable Entire cohort
(n = 860)
Age <70 years (non-elderly)
(n = 522)
Age ≥70 years (elderly)
(n = 338)
P-value
Basic demographics
Age, years, mean  SD 65.2  11.7 57.9  8.8 76.4  4.4 <0.001
<70 years, n (%) 522 (60.7%)
≥70 years, n (%) 338 (39.3%)
Gender, n (%) 0.656
Male 494 (57.4%) 303 (58.0%) 191 (56.5%)
Female 366 (42.6%) 219 (42.0%) 147 (43.5%)
BMI, kg/m2, mean  SD 27.4  5.3 27.8  5.8 26.8  4.4 0.006
Comorbidities, n (%)
Obesity (BMI ≥30 kg/m2) 235 (27.3%) 162 (31.0%) 73 (21.6%) 0.002
Any alcohol use 453 (59.5%) 282 (63.4%) 171 (54.1%) 0.010
Current smoker 139 (16.2%) 110 (21.1%) 29 (8.6%) <0.001
Steroid use within 6 monthsa 38 (4.4%) 21 (4.0%) 17 (5.0%) 0.483
CADa 159 (18.5%) 64 (12.3%) 95 (28.1%) <0.001
COPDa 65 (7.6%) 30 (5.8%) 35 (10.4%) 0.012
Hypertensiona 461 (53.6%) 229 (43.9%) 232 (68.6%) <0.001
Diabetesa 234 (27.2%) 132 (25.3%) 102 (30.2%) 0.116
Renal diseasea 78 (9.1%) 41 (7.9%) 37 (11.0%) 0.123
Liver diseasea 56 (6.5%) 41 (7.9%) 15 (4.4%) 0.047
History of VTEa 51 (5.9%) 32 (6.1%) 19 (5.6%) 0.758
Vascular diseasea 109 (12.7%) 43 (8.2%) 66 (19.5%) <0.001
Clinical symptoms, n (%)
History of cholangitis 40 (4.7%) 24 (4.6%) 16 (4.7%) 0.926
History of jaundice 413 (48.0%) 246 (47.1%) 167 (49.4%) 0.513
History of pancreatitis
Any 140 (16.3%) 104 (19.9%) 36 (10.7%) 0.003
Acute 101 (11.7%) 73 (14.0%) 28 (8.3%) 0.001
Chronic 39 (4.5%) 31 (5.9%) 8 (2.4%)
Anaemiab
Haemoglobin, g/dl, mean  SD 12.9  1.7 13.0  1.7 12.6  1.6 0.001
Haemoglobin ≤10.5 g/dl, n (%) 154 (17.9%) 83 (15.9%) 71 (21.0%) 0.057
Operative characteristics
ASA class, n (%)
Class III/IV versus Class I/II 516 (60.6%) 275 (53.2%) 241 (71.9%) <0.001
Laparoscopic Whipple, n (%) 281 (32.7%) 168 (32.2%) 113 (33.4%) 0.703
Converted, n (%) 20 (2.3%) 15 (2.9%) 5 (1.5%) 0.185
PD versus PPPD, n (%) 103 (12.0%) 60 (11.5%) 43 (12.7%) 0.588
Vein resection, n (%) 132 (15.4%) 75 (14.4%) 57 (16.9%) 0.321
Operative drain, n (%) 692 (80.5%) 420 (80.5%) 272 (80.5%) 0.996
Total operation time, min, mean  SD 371.9  96.5 378.7  95.6 361.4  97.2 0.010
EBL, ml, mean  SD 713.7  820.1 728.9  711.3 690.3  965.0 0.501
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comparing OPD with TLPD. No differences in the results were
noted and hence the as-treated analysis is presented. Based
upon these univariate analyses, multivariable logistic regression
models were constructed to risk-adjust outcomes and evaluate
for goodness of fit. All analyses were performed using SAS Ver-
sion 9.3 (SAS Institute, Inc., Cary, NC, USA).
Results
Descriptive statistics
The entire cohort consisted of 860 patients who met the study
inclusion and exclusion criteria for evaluation. These included
522 (60.7%) non-elderly patients and 338 (39.3%) elderly
patients. Among the elderly subgroup, 113 (33.4%) patients
underwent TLPD and 225 (66.6%) underwent OPD. The age
range of the entire cohort was 26.7–91.2 years. The mean 
standard deviation postoperative follow-up time to data acqui-
sition in the entire cohort was 48.6  43.8 days from the day
of surgery; the median length of follow-up was 39 days. Basic
demographics for the entire cohort and the elderly subgroup
are summarized in Tables 1 and 2, respectively.
A comparison of baseline characteristics in the elderly and
non-elderly patient subgroups showed differences in age (by
definition) and body mass index (BMI). Elderly patients had a
lower BMI than non-elderly patients. Differences in comorbidi-
ties were noted: elderly patients showed decreased rates of obe-
sity, alcohol use and tobacco use, and increased rates of
coronary artery disease, chronic obstructive pulmonary disease,
hypertension, liver disease and vascular disease. Elderly patients
also had higher American Society of Anesthesiologists (ASA)
class scores, shorter operative times, and a decreased likelihood
of receiving neoadjuvant therapy. Clinical presentations also
differed. Elderly patients were more likely to have a history of
pancreatitis or preoperative anaemia. A cut-off haemoglobin
level of 10.5 g/dl represented the 25th percentile for this cohort
and was used as an indicator variable for preoperative anaemia
for the purposes of multivariate analysis.
Evaluations of the subgroups of elderly patients submitted
to OPD and TLPD, respectively, showed minimal differences
in baseline comorbidities. There were differences in gender in
that female patients represented a greater proportion of the
TLPD subgroup but not the OPD subgroup. There were also
differences in current alcohol use, which was lower in the
TLPD group than in the OPD group. In the multivariate anal-
ysis, attempts to risk-adjust for alcohol use were compromised
Table 1 Continued
Variable Entire cohort
(n = 860)
Age <70 years (non-elderly)
(n = 522)
Age ≥70 years (elderly)
(n = 338)
P-value
Diagnostic characteristics
Malignant diagnosis, n (%) 648 (75.5%) 381 (73.3%) 267 (79.0%) 0.057
Diagnosisc, n (%)
Pancreatic cancer 416 (48.4%) 242 (46.4%) 174 (51.5%) <0.001
Cholangiocarcinoma 35 (4.1%) 16 (3.1%) 19 (5.6%)
Duodenal cancer 28 (3.3%) 15 (2.9%) 13 (3.9%)
Ampullary cancer 97 (11.3%) 55 (10.5%) 42 (12.4%)
Renal cell carcinoma 9 (1.1%) 3 (0.6%) 6 (1.8%)
Neuroendocrine tumour 69 (8.0%) 55 (10.4%) 14 (4.1%)
Pancreatitis 34 (4.0%) 28 (5.4%) 6 (1.8%)
Cystic neoplasm 13 (1.5%) 11 (2.1%) 2 (0.6%)
IPMN 97 (11.3%) 46 (8.8%) 51 (15.1%)
Other 62 (7.2%) 51 (9.8%) 11 (3.3%)
Neoadjuvant therapyd, n (%) 71 (8.3%) 55 (10.5%) 16 (4.7%) 0.003
Percentage values for categorical variables reflect proportions according to the total available data for that variable.
a
Any steroid use: systemic steroid administration within 6 months of operation. CAD: history of myocardial infarction, percutaneous coronary inter-
vention, or coronary artery bypass graft. COPD: documented medical history supported by radiological and/or functional evaluation. Hyperten-
sion: elevated blood pressure requiring medications for adequate control. Diabetes: impaired glycaemic regulation requiring insulin, oral
hypoglycaemic agents, and/or dietary modification. Renal disease: impaired renal function based on biochemical evaluation and/or solitary
kidney. Liver disease: history of viral hepatitis, steatohepatitis, or cirrhosis. History of VTE: any prior history of deep vein thrombosis and/or
pulmonary embolus. Vascular disease: peripheral arterial disease and/or arterial aneurysm with or without repair.
b
Clinical symptoms documented were based upon initial presentation. Anaemia was defined as a haemoglobin level ≤10.5 g/dl, which represented
the 25th percentile of the cohort, for the purposes of risk-adjusted multivariate analyses.
c
Diagnosis: cystic neoplasm does not include IPMN. Other: sarcoma, lymphoma, gastrointestinal stromal tumour, adenoma, benign stricture, solid
pseudopapillary epithelial neoplasm, etc.
d
Neoadjuvant therapy: any preoperative chemotherapy, radiation therapy or both.
ASA, American Society of Anesthesiologists; BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary dis-
ease; EBL, estimated blood loss; IPMN, intraductal papillary mucinous neoplasm; PD, pancreatoduodenectomy without pylorus preservation;
PPPD, pylorus-preserving pancreatoduodenectomy; SD, standard deviation; VTE, venous thromboembolism.
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Table 2 Baseline characteristics in the elderly patient subgroup
Variable Elderly only
(n = 338)
Laparoscopic PD
(n = 113)
Open PD
(n = 225)
P-value
Basic demographics
Age, years, mean  SD 76.4  4.4 76.5  4.3 76.4  4.5 0.816
Gender, n (%) 0.003
Male 191 (56.5%) 51 (45.1%) 140 (62.2%)
Female 147 (43.5%) 62 (54.9%) 85 (37.8%)
BMI, kg/m2, mean  SD 26.8  4.4 26.9  4.7 26.8  4.3 0.919
Comorbidities, n (%)
Obesity (BMI ≥30 kg/m2) 73 (21.6%) 28 (24.8%) 45 (20.0%) 0.314
Any alcohol use 171 (54.1%) 47 (42.3%) 124 (60.5%) 0.002
Current smoker 29 (8.6%) 9 (8.0%) 20 (8.9%) 0.775
Steroid use within 6 monthsa 17 (5.0%) 9 (8.0%) 8 (3.6%) 0.080
CADa 95 (28.1%) 34 (30.1%) 61 (27.1%) 0.566
COPDa 35 (10.4%) 15 (13.3%) 20 (8.9%) 0.212
Hypertensiona 232 (68.6%) 78 (69.0%) 154 (68.4%) 0.913
Diabetesa 102 (30.2%) 29 (25.7%) 73 (32.4%) 0.200
Renal diseasea 37 (11.0%) 12 (10.6%) 25 (11.1%) 0.891
Liver diseasea 15 (4.4%) 6 (5.3%) 9 (4.0%) 0.581
History of VTEa 19 (5.6%) 6 (5.3%) 13 (5.8%) 0.860
Vascular diseasea 66 (19.5%) 26 (23.0%) 40 (17.8%) 0.2524
Clinical symptoms, n (%)
History of cholangitis 16 (4.7%) 6 (5.3%) 10 (4.4%) 0.724
History of jaundice 167 (49.4%) 47 (41.6%) 120 (53.3%) 0.042
History of pancreatitis
Any 36 (10.7%) 15 (13.3%) 21 (9.3%) 0.268
Acute 28 (8.3%) 15 (13.3%) 13 (5.8%) 0.010
Chronic 8 (2.4%) 0 (0%) 8 (3.6%)
Anaemiab
Haemoglobin, g/dl, mean  SD 12.6  1.6 12.8  1.5 12.5  1.6 0.099
Haemoglobin ≤10.5 g/dl, n (%) 71 (21.0%) 21 (18.6%) 50 (22.2%) 0.439
Operative characteristics
ASA class
Class III/IV versus class I/II, n (%) 241 (71.9%) 83 (74.1%) 158 (70.9%) 0.532
PD versus PPPD, n (%) 43 (12.7%) 13 (11.5%) 30 (13.3%) 0.634
Vein resection, n (%) 57 (16.9%) 18 (15.9%) 39 (17.3%) 0.745
Operative drain, n (%) 272 (80.5%) 64 (56.6%) 208 (92.4%) <0.001
Total operation time, min, mean  SD 361.4  97.2 364.5  110.6 359.8  90.0 0.681
EBL, ml, mean  SD 690.3  965.0 344.7  346.5 868.8  1118.2 <0.001
Diagnostic characteristics
Malignant diagnosis, n (%) 267 (79.0%) 75 (66.4%) 192 (85.3%) <0.001
Diagnosisc, n (%) <0.001
Pancreatic cancer 174 (51.5%) 53 (46.9%) 121 (53.8%)
Cholangiocarcinoma 19 (5.6%) 4 (3.5%) 15 (6.7%)
Duodenal cancer 13 (3.9%) 2 (1.8%) 11 (4.9%)
HPB 2015, 17, 909–918 ª 2015 International Hepato-Pancreato-Biliary Association
HPB 913
by the number of unavailable data for this variable. Notably,
there were differences in indications for PD, whereby malignant
diagnoses were more common in the OPD group. Differences in
indications for PD were also reflected in differences in clinical
presentation in that the likelihood of a history of pancreatitis
was greater in TLPD patients and the likelihood of a history of
jaundice was lower in TLPD patients than in OPD patients.
Fewer operative drains were placed in patients in the TLPD
subgroup compared with those in the OPD subgroup, based on
surgeon practice preference. Estimated blood loss was also lower
in the TLPD subgroup than in the OPD subgroup. There were
no differences in venous resection, pylorus preservation or oper-
ative time between the TLPD and OPD subgroups.
Entire cohort: elderly versus non-elderly patients
Univariate and multivariate analyses for the entire cohort com-
paring outcomes in elderly and non-elderly patients, respec-
tively, are summarized in Table 3. There were no differences
between elderly and non-elderly patients in terms of postopera-
tive 30-day or in-hospital mortality, unplanned ICU admission,
reoperation requiring a general anaesthetic, readmission, surgi-
cal site infection (superficial or deep with or without wound
or fascial dehiscence), POPF (Grades B and C) or PPH (Grades
B and C). On univariate analysis, elderly patients had a 59%
increased odds of major morbidity (Clavien–Dindo Grade IIIb
complication and higher; P = 0.036), 84% increased odds of
DGE (Grades B and C; P < 0.001), 71% increased odds of a
respiratory complication (failure, prolonged ventilator support
or pneumonia; P = 0.014), 55% increased odds of blood trans-
fusion (receipt of any PRBC during the course of hospitaliza-
tion; P = 0.003), more than three-fold increased odds of
cardiac complications (myocardial infarction, arrest, failure or
unstable arrhythmia; P < 0.001), and almost nine-fold
increased odds of a discharge disposition other than home
(skilled nursing facility, other hospital or rehabilitation centre;
P < 0.001) than non-elderly patients. The association between
elderly age and these outcomes was confirmed on multivariate
analyses controlling for gender, obesity, current smoker status,
coronary artery disease, chronic obstructive pulmonary disease,
hypertension, liver disease, vascular disease, history of pancre-
atitis, operative time, preoperative anaemia, ASA class and
neoadjuvant therapy. After risk adjustment, elderly age was no
longer predictive of postoperative major morbidity
(P = 0.677). With respect to hospital resource utilization, the
median number of units of PRBC transfused was greater in
elderly than in non-elderly patients (1 unit versus 0 units;
P < 0.001). Median LoS was also greater in elderly than in
non-elderly patients (9 days versus 8 days; P < 0.001).
Elderly subgroup: OPD versus TLPD
Univariate and multivariate analyses for the elderly subgroup
comparing outcomes between OPD and TLPD are summarized
in Table 4. There were no differences between OPD and TLPD
in terms of postoperative 30-day or in-hospital mortality, major
morbidity, unplanned ICU admission, reoperation requiring a
general anaesthetic, readmission, surgical site infection, POPF
(Grades B and C) or PPH (Grades B and C). On univariate anal-
ysis, OPD was associated with 72% increased odds for DGE
Table 2 Continued
Variable Elderly only
(n = 338)
Laparoscopic PD
(n = 113)
Open PD
(n = 225)
P-value
Ampullary cancer 42 (12.4%) 9 (8.0%) 33 (14.7%)
Renal cell carcinoma 6 (1.8%) 0 6 (2.7%)
Neuroendocrine tumour 14 (4.1%) 6 (5.3%) 8 (3.6%)
Pancreatitis 6 (1.8%) 3 (2.7%) 3 (1.3%)
Cystic neoplasm 2 (0.6%) 0 (0%) 2 (0.9%)
IPMN 51 (15.1%) 29 (25.7%) 22 (9.8%)
Other 11 (3.3%) 7 (6.2%) 4 (1.8%)
Neoadjuvant therapyd, n (%) 16 (4.7%) 5 (4.4%) 11 (4.9%) 0.850
Percentage values for categorical variables reflect proportions according to the total available data for that variable.
a
Any steroid use: systemic steroid administration within 6 months of operation. CAD: history of myocardial infarction, percutaneous coronary inter-
vention, or coronary artery bypass graft. COPD: documented medical history supported by radiological and/or functional evaluation. Hyperten-
sion: elevated blood pressure requiring medications for adequate control. Diabetes: impaired glycaemic regulation requiring insulin, oral
hypoglycaemic agents, and/or dietary modification. Renal disease: impaired renal function based on biochemical evaluation and/or solitary
kidney. Liver disease: history of viral hepatitis, steatohepatitis, or cirrhosis. History of VTE: any prior history of deep vein thrombosis and/or
pulmonary embolus. Vascular disease: peripheral arterial disease and/or arterial aneurysm with or without repair.
b
Clinical symptoms documented were based upon initial presentation. Anaemia was defined as a haemoglobin level ≤10.5 g/dl, which represented
the 25th percentile of the cohort, for the purposes of risk-adjusted multivariate analyses.
c
Other: sarcoma, lymphoma, gastrointestinal stromal tumour, adenoma, benign stricture, solid pseudopapillary epithelial neoplasm, etc.
d
Neoadjuvant therapy: any preoperative chemotherapy, radiation therapy or both.
ASA, American Society of Anesthesiologists; BMI, body mass index; CAD, coronary artery disease; COPD, chronic obstructive pulmonary dis-
ease; EBL, estimated blood loss; IPMN, intraductal papillary mucinous neoplasm; PD, pancreatoduodenectomy without pylorus preservation;
PPPD, pylorus-preserving pancreatoduodenectomy; SD, standard deviation; VTE, venous thromboembolism.
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(Grades B and C) and more than three-fold increased odds for
any blood transfusion compared with TLPD. The association
between OPD and these outcomes was confirmed on multivari-
ate analyses controlling for gender, history of pancreatitis,
history of jaundice, malignant diagnosis and preoperative anae-
mia. Notably, there were no differences in the odds for cardiores-
piratory complications or discharge disposition other than home
between OPD and TLPD. With respect to hospital resource
utilization, the median number of PRBC units transfused was
greater in the OPD subgroup than in the TLPD subgroup
(2 units versus 0 units; P < 0.001) (Fig. 1a). Median LoS was
also greater in the OPD subgroup than in the TLPD subgroup
(9 days versus 8 days; P < 0.001) (Fig. 1b).
Discussion
Key findings in this study show, firstly, that elderly patients are
at increased risk for cardiac complications (adjusted OR 3.21,
P < 0.001), respiratory complications (adjusted OR 1.68,
P = 0.041), DGE (adjusted OR 1.73, P = 0.003), receipt of
blood transfusion (adjusted OR 1.41, P = 0.048), discharge dis-
position other than home (adjusted OR 8.14, P < 0.001), and
increased hospital LoS (9 days compared with 8 days;
P < 0.001). Secondly, the present findings show that TLPD
does not mitigate the increased risk for cardiorespiratory com-
plications. The advantages of TLPD over OPD in elderly
patients include a decreased likelihood of blood transfusion
(adjusted OR 2.89, P < 0.001, OPD versus TLPD), DGE
(adjusted OR 1.80, P = 0.032, OPD versus TLPD), and shorter
LoS (9 days versus 8 days; P < 0.001, OPD versus TLPD).
These results are supported by those of other studies in rela-
tion to postoperative morbidity but are discordant in relation
to postoperative mortality.8,9,18 A recent meta-analysis pooled
seven studies comprising over 5000 patients and demonstrated
that elderly patients (defined as those aged 76–80 years) had
increased postoperative mortality compared with non-elderly
Table 3 Outcomes for the entire cohort (elderly versus non-elderly patients)
Outcome Non-elderly
(n = 522)
n (%)
Elderly
(n = 338)
n (%)
Univariatea OR Univariate
P-value
Multivariateb OR (95% CI) Multivariate
P-value
Mortalityc 7 (1.3%) 8 (2.4%) 1.78 0.252 1.49 (0.44–5.08) 0.523
Major morbidityd 46 (8.8%) 45 (13.3%) 1.59 0.036 1.53 (0.93–2.53) 0.677
ICU admissione 62 (11.9%) 55 (16.3%) 1.44 0.066 1.40 (0.89–2.22) 0.145
Reoperationf 24 (4.6%) 18 (5.3%) 1.17 0.629 0.98 (0.49–1.95) 0.943
Readmissiong 87 (16.7%) 56 (16.7%) 1.00 0.985 1.44 (0.94–2.19) 0.092
POPFh (Grade B/C) 119 (22.8%) 83 (24.6%) 1.10 0.552 1.05 (0.79–1.52) 0.783
PPHh (Grade B/C) 46 (8.8%) 28 (8.3%) 0.94 0.787 0.881 (0.50–1.54) 0.657
DGEh (Grade B / C) 104 (19.9%) 106 (31.4%) 1.84 <0.001 1.73 (1.21–2.47) 0.003
Cardiac eventi 41 (7.8%) 81 (24.0%) 3.70 <0.001 3.21 (2.03–5.06) <0.001
Respiratory eventj 45 (8.6%) 47 (13.9%) 1.71 0.014 1.68 (1.02–2.78) 0.041
SSIk 134 (25.7%) 100 (29.6%) 1.22 0.208 1.29 (0.91–1.82) 0.154
Transfusionl 161 (31.2%) 136 (41.3%) 1.55 0.003 1.41 (1.00–1.98) 0.048
Discharge dispositionm 8 (1.6%) 41 (12.4%) 9.00 <0.001 8.14 (3.41–19.5) <0.001
a
Univariate OR: calculated based on frequency tables with P-values obtained from chi-squared tests or Fisher’s exact test if cell counts were ≤5
for any given event.
b
Multivariate logistic regression computed ORs that controlled for the following variables: elderly, sex, obesity, current smoker status, coronary
artery disease, chronic obstructive pulmonary disease, hypertension, liver disease, vascular disease, history of pancreatitis, operative time, preop-
erative anaemia, ASA class, and neoadjuvant therapy.
c
Mortality: in-hospital or 30-day death from date of surgery.
d
Major morbidity: Grade IIIb or higher complication based on Clavien–Dindo classification of surgical complications.
e
Unplanned/unanticipated ICU admission, excluding monitored stepdown units.
f
Reoperation: any major reoperation within 30 days of surgery or during course of hospitalization requiring a general anaesthetic.
g
Readmission: any hospital readmission within 30 days of date of surgery.
h
Classifications of POPF, PPH and DGE are based upon International Study of Pancreatic Surgery Group definitions.
i
Cardiac event: any myocardial infarction, cardiac arrest, unstable arrhythmias requiring intervention and transfer to monitored unit, or congestive
heart failure.
j
Respiratory event: any respiratory failure necessitating positive pressure ventilation, prolonged ventilatory support >48 h, or pneumonia.
k
SSI: any superficial, deep/organ space infection or wound/fascial dehiscence.
l
Transfusion: receipt of any packed red blood cells during the course of hospitalization.
m
Discharge disposition: discharge to skilled nursing facility, rehabilitation centre or other hospital compared with home, with or without home
health services. Odds ratios calculated excluded expired patients.
95% CI, 95% confidence interval; ASA, American Society of Anesthesiologists; DGE, delayed gastric emptying; ICU, intensive care unit; OR, odds
ratio; POPF, postoperative pancreatic fistula; PPH, post-pancreatectomy haemorrhage; SSI, surgical site infection.
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patients undergoing PD.9 When elderly patients were defined
as those aged >80 years, they were found to have increased risk
for postoperative complications compared with non-elderly
patients.9 When elderly patients were defined as those aged
>75 years, they were found to have increased risk for
pulmonary complications compared with non-elderly patients.9
In another study conducted in patients undergoing pancreatec-
tomy, those aged >75 years had increased rates of mortality,
ICU admission, major cardiac events, and discharge to skilled
nursing facilities compared with patients aged 16–74 years.8
The present results confirm prior findings that elderly
patients are more likely to have postoperative cardiorespiratory
complications.8,9 However, they do not demonstrate an
increased risk for postoperative mortality in elderly patients.
This finding may reflect differences between this and other
studies in definitions of ‘elderly patients’ or may indicate that
the present study is underpowered to detect statistically signifi-
cant differences for such a rare event, given that the overall
mortality rate in the study cohort was 1.7%. The current study
also did not demonstrate increased risk for ICU admission or
major morbidity after risk adjustment. The present authors
acknowledge that the inclusion criteria for ICU admission were
stringent in that they focused on those patients with
unplanned admissions for treatment or invasive monitoring.
Admissions to the ICU that had been scheduled preoperatively
for postoperative cardiorespiratory monitoring and equivalent
monitoring outside the ICU were not categorized as ICU
admissions. Major morbidity in this study was defined using
the Clavien–Dindo system of classification rather than other
modifications or unique classification systems.8,9,13,24
Only one prior study has evaluated minimally invasive
approaches to PD in elderly patients.18 This single-institution,
retrospective review of 41 consecutive patients evaluated only
patients undergoing robotic PD. In a comparison of elderly
patients (defined as those aged >70 years) and non-elderly
patients, Buchs et al.18 identified no differences in operative
Table 4 Outcomes for the elderly subgroup (open versus laparoscopic pancreatoduodenectomy)
Outcome Laparoscopy
(n = 113)
n (%)
Open
(n = 225)
n (%)
Univariatea
OR
Univariate
P-value
Multivariateb
OR (95% CI)
Multivariate
P-value
Mortalityc 5 (4.4%) 3 (1.3%) 0.29 0.123 0.35 (0.07–1.67) 0.186
Major morbidityd 11 (9.7%) 34 (15.1%) 1.65 0.170 1.83 (0.86–3.90) 0.116
ICU admissione 16 (14.2%) 39 (17.3%) 1.27 0.456 1.28 (0.66–2.47) 0.462
Reoperationf 3 (2.7%) 15 (6.7%) 2.62 0.197 3.25 (0.87–12.1) 0.079
Readmissiong 19 (17.1%) 37 (16.5%) 0.96 0.890 1.03 (0.53–2.00) 0.927
POPFh (Grade B/C) 26 (23.0%) 57 (25.3%) 1.14 0.640 1.02 (0.59–1.79) 0.934
PPHh (Grade B/C) 9 (8.0%) 19 (8.4%) 1.07 0.880 1.11 (0.47–2.63) 0.809
DGEh (Grade B/C) 27 (23.9%) 79 (35.1%) 1.72 0.036 1.80 (1.05–3.07) 0.032
Cardiac eventi 25 (22.1%) 56 (24.9%) 1.17 0.574 1.11 (0.63–1.95) 0.712
Respiratory eventj 14 (12.4%) 33 (14.7%) 1.22 0.568 1.30 (0.65–2.63) 0.458
SSIk 32 (28.3%) 68 (30.2%) 1.10 0.718 0.92 (0.54–1.57) 0.771
Transfusionl 26 (23.4%) 110 (50.5%) 3.33 <0.001 2.89 (1.70–4.91) <0.001
Discharge dispositionm 10 (9.3%) 31 (14.0%) 1.59 0.224 1.72 (0.80–3.81) 0.161
a
Univariate OR: calculated based on frequency tables with P-values obtained from chi-squared tests or Fisher’s exact test if cell counts were ≤5
for any given event.
b
Multivariate logistic regression computed ORs that controlled for the following variables: elderly, sex, obesity, current smoker status, coronary
artery disease, chronic obstructive pulmonary disease, hypertension, liver disease, vascular disease, history of pancreatitis, operative time, preop-
erative anaemia, ASA class and neoadjuvant therapy.
c
Mortality: in-hospital or 30-day death from date of surgery.
d
Major morbidity: Grade IIIb or higher complication based on Clavien–Dindo classification of surgical complications.
e
Unplanned/unanticipated ICU admission, excluding monitored stepdown units.
f
Reoperation: any major reoperation within 30 days of surgery or during course of hospitalization requiring a general anaesthetic.
g
Readmission: any hospital readmission within 30 days of date of surgery.
h
Classifications of POPF, PPH and DGE are based upon International Study of Pancreatic Surgery Group definitions.
i
Cardiac event: any myocardial infarction, cardiac arrest, unstable arrhythmias requiring intervention and transfer to monitored unit, or congestive
heart failure.
j
Respiratory event: any respiratory failure necessitating positive pressure ventilation, prolonged ventilatory support >48 h, or pneumonia.
k
SSI: any superficial, deep/organ space infection or wound/fascial dehiscence.
l
Transfusion: receipt of any packed red blood cell during the course of hospitalization.
m
Discharge disposition: discharge to skilled nursing facility, rehabilitation centre, or other hospital compared to home, with or without home health
services. Odds ratios calculated excluded expired patients.
95% CI, 95% confidence interval; ASA, American Society of Anesthesiologists; DGE, delayed gastric emptying; ICU, intensive care unit; OR, odds
ratio; POPF, postoperative pancreatic fistula; PPH, post-pancreatectomy haemorrhage; SSI, surgical site infection.
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time, blood loss, conversion rate, postoperative mortality or
overall morbidity between the two groups. The authors con-
cluded that robotic PD could be safely offered to elderly
patients and that age should not be a contraindication to this
procedure.18 The present study is distinct from that prior
report18 in that it focused specifically on elderly patients in its
comparison of operative approaches in order to determine if
TLPD would offer advantages to this higher-risk group.
Several limitations of this study warrant discussion. The
retrospective nature of the study makes it prone to selection
bias. As the elderly subgroup analysis shows, the TLPD sub-
group showed greater proportions of female patients, non-alco-
holic patients and patients with non-malignant indications for
resection than the OPD subgroup. Although there is no
intended bias in the selection of patients for TLPD, these vari-
ables are known to affect outcomes and therefore risk adjust-
ment was performed to control for these differences.25 The
present authors speculate that these differences may be
explained by referral patterns as the choice of operative
approach is based on surgeon preference because only one sur-
geon at the study institution performs TLPD. Additional com-
parisons based on intention-to-treat analyses (in which
patients in whom TLPD was converted to OPD were included
in the TLPD group) found no differences in the results.
Moreover, there were no significant differences in operative
variables such as prevalence of venous resection, operative time
and pylorus preservation between the TLPD and OPD
subgroups.
In conclusion, the present study suggests that morbidity but
not mortality is increased in elderly patients submitted to PD
compared with non-elderly patients. The laparoscopic
approach may improve selected perioperative outcomes in
elderly patients, such as by decreasing requirements for blood
transfusion and the incidence of DGE, and may reduce hospi-
tal LoS, but it does not lower the risk for cardiorespiratory
complications. The indications for PD should not be expanded
based on ability to perform the procedure with minimally
invasive approaches in the elderly patient population.
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